Amphastar Pharmaceuticals, Inc.
—- Market cap
- —
- Debt
- +$43.70M
- Cash
- −$282.81M
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: AMPH stock price vs LEG: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at LEG's multiple
Needs LEG P/E.
Implied fair value · at AMPH's multiple
Needs AMPH P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: AMPH FY 2025 (ended Dec 31, 2025) · LEG FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
Amphastar Pharmaceuticals, Inc. · implied price per share
Bear
$44.56
Base
$52.42
Bull
$60.29
LEGGETT & PLATT INC · implied price per share
Bear
$15.36
Base
$18.07
Bull
$20.78
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.06x
1.47x
Net debt / EBITDA
Leverage against operating earnings
-0.99x
1.65x
Cash and equivalents
Liquid reserves on the balance sheet
$282.81M
$587.40M
Total debt
Interest-bearing obligations outstanding
$43.70M
$1.50B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BRISTOL MYERS SQUIBB CO
AMPH vs BMY
TEVA PHARMACEUTICAL INDUSTRIES LTD
AMPH vs TEVA
Bausch Health Companies Inc.
AMPH vs BHC
PERRIGO Co plc
AMPH vs PRGO
ANI PHARMACEUTICALS INC
AMPH vs ANIP
LA-Z-BOY INC
AMPH vs LZB
HNI CORP
AMPH vs HNI
STEELCASE INC
AMPH vs SCS
Avery Dennison Corp
AMPH vs AVY
METTLER TOLEDO INTERNATIONAL INC/
AMPH vs MTD
AMETEK INC/
AMPH vs AME
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
Live quote